Drugs.com

DECEMBER 4, 2024

4, 2024 -- About a third of America’s pharmacies have closed since 2010, amounting to an “unprecedented decline” in neighborhood drug stores, a new study finds.The drop began in 2018, primarily driven by store closures among chain ph. WEDNESDAY, Dec.

Pharmacy 246

Pharmacy Drugs 246

Drugs.com

OCTOBER 1, 2024

government trials did between 2018 and 2022, new research shows.The study -- conducted by researchers at Fred Hutch Cancer Center in. TUESDAY, Oct. 1, 2024 -- Clinical trials sponsored by Big Pharma enrolled eight times as many patients as U.S.-government

Trials 242

Trials Clinical Trials Government Drugs 242

Drugs.com

JUNE 22, 2023

THURSDAY, June 22, 2023 -- The number of cases of vape product-related poisonings reported to America’s poison control centers doubled between 2018 and early 2023, a new report finds. The bulk of those cases were in kids under the age of.

Production 265

Production 265

Drugs.com

AUGUST 8, 2024

8, 2024 -- Kids and teens around the world are consuming more sugary drinks, increasing their risk of future health problems, a new study finds.Young people consumed nearly 23% more sugar-sweetened beverages in 2018 compared to 1990. THURSDAY, Aug.

239

239

BioPharma Drive: Drug Pricing

JUNE 29, 2023

Sigilon Therapeutics, a biotech that’s been collaborating with Lilly since 2018, has agreed to be bought for up to $310 million in the pharma’s second announced buyout this month.

Therapies 256

Therapies 256

Science Daily: Pharmacology News

JUNE 23, 2023

Researchers used a new approach with satellite data to estimate the storage variations of 7,245 global reservoirs from 1999 to 2018. Over the past two decades, global reservoirs have become increasingly empty despite an overall increase in total storage capacity due to the construction of new reservoirs.

Research 235

Research 235

Science Daily: Pharmacology News

FEBRUARY 6, 2024

in 2018, a new study shows. Daily exposure to chemicals used in the manufacture of plastic food containers and many cosmetics may be tied to nearly 56,600 preterm births in the U.S. The resulting medical costs, the authors of the report say, were estimated to reach a minimum of $1.6 billion and as much as $8.1

233

233

BioPharma Drive: Drug Pricing

MAY 22, 2024

The deal, only Biogen’s third since the start of 2018, is a sign the company is open to branching out beyond the neurological drugs that have long been its focus.

Drugs 196

Drugs 196

BioPharma Drive: Drug Pricing

MARCH 17, 2024

The biotech, formed as a successor to a company Roche acquired in 2018, has two drugs in clinical testing for neurological and immune diseases.

Disease 201

Disease Drugs 201

BioPharma Drive: Drug Pricing

OCTOBER 22, 2024

A medicine the pharma acquired in a $430 million buyout of Visterra in 2018 succeeded in a Phase 3 trial in IgA nephropathy, a crowded corner of drug research.

Disease 167

Disease Drugs Drug Research Trials 167

BioPharma Drive: Drug Pricing

OCTOBER 4, 2024

Having already been on a winding journey, Enjaymo, which Sanofi acquired through a 2018 buyout of Bioverativ, is now headed to Recordati as part of a deal announced Friday.

Disease 167

Disease Drugs 167

BioPharma Drive: Drug Pricing

JANUARY 2, 2025

The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end of recent annual tallies.

FDA Approval 167

FDA Approval FDA Drugs 167

Science Daily: Pharmacology News

JULY 27, 2023

In 2018, researchers found two roundworms (nematode) species in the Siberian Permafrost. Some organisms, such as tardigrades, rotifers, and nematodes, can survive harsh conditions by entering a dormant state known as 'cryptobiosis.'

Research 189

Research 189

Agency IQ

SEPTEMBER 22, 2023

Following a 2018 draft framework, FDA unveils long-awaited PDURS draft guidance A long-awaited draft guidance on Prescription Drug Use-Related Software (PDURS) outlines when information from digital health tools could be represented on prescription drug labeling. Digital technologies as drug labeling: An intro to PDURS What is PDURS?

FDA 59

FDA Production Drugs 59

Science Daily: Pharmacology News

OCTOBER 23, 2024

A recovery program increased their population by 2010, but from 2014 to 2018, it fell to 30% of its peak due to a new acanthocephalan parasite, exacerbated by a prolonged drought. In the 1990s, the San Miguel Island fox nearly went extinct, with numbers dropping to just 15.

Research 156

Research 156

Drugs.com

FEBRUARY 17, 2025

17, 2025 -- Millions of Americans have sought help for gambling addiction in the wake of a 2018 U.S. MONDAY, Feb. Supreme Court decision that allowed states to legalize sports betting.That's among the key findings in a new study published Feb.

146

146

Drugs.com

MARCH 17, 2025

MONDAY, March 17, 2025 -- Nearly 1 in 3 children live with a chronic condition that could significantly affect their health for the rest of their lives, a new study says.Chronic illnesses affected more than 30% of children ages 5 to 17 by 2018, up.

146

146

Drugs.com

JUNE 9, 2023

Researchers found that between 2018 and 2021, U.S. FRIDAY, June 9, 2023 -- Young American adults have doubled their use of non-LSD hallucinogens in just a few years, a new report warns. adults aged 19 to 30 increased their use of mescaline, peyote,

Research 148

Research 148

Covalent Modifiers

FEBRUARY 6, 2024

However, there has been a resurgence in covalent drug design following the success of several covalent drugs such as boceprevir (2011), ibrutinib (2013), neratinib (2017), dacomitinib (2018), zanubrutinib (2019), and many others.

Drugs 182

Drugs Research 182

SCIENMAG: Medicine & Health

FEBRUARY 14, 2024

Significantly more babies were born on a weekday instead of weekend day or holiday, reveals a large-scale analysis of 21 million births in Japan over almost four decades published February 14, 2024 in the open-access journal PLOS ONE by Miho Sassa from the University of Tokyo, Japan, and colleagues.

84

84

Drug Patent Watch

DECEMBER 10, 2024

Hyderabad’s Pharma City, which has been under construction since 2018, is a significant example of this initiative. These parks are critical in reducing India’s reliance on China and making the country an attractive location for pharmaceutical manufacturing.

Government 97

Government Pharmacy Drugs Pharmaceuticals 97

Crown Bioscience

JUNE 6, 2024

This marks the second-highest count in the past 30 years, with the highest being 59 new drug approvals in 2018 and represents an impressive 50% increase in drugs approved in 2022. In a significant development, the US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) approved 55 new drugs in 2023.

FDA Approval 105

FDA Approval FDA Drugs Research 105

Advarra

JULY 26, 2022

The 2018 Farm Bill. The 2018 Farm Bill removed hemp from the Controlled Substance Act. Importantly, the 2018 Farm Bill preserved FDA authority to regulate products with cannabis or cannabis-derived compounds under the Federal Food, Drug, and Cosmetic (FD&C) Act and Section 351 of the Public Health Service Act.

Regulations 97

Regulations Research FDA FDA Approval 97

Agency IQ

SEPTEMBER 22, 2023

Following a 2018 draft framework, FDA unveils long-awaited PDURS draft guidance A long-awaited draft guidance on Prescription Drug Use-Related Software (PDURS) outlines when information from digital health tools could be represented on prescription drug labeling. See AgencyIQ’s full analysis of the 2018 framework, and industry response, here.]

FDA 40

FDA Biosimilars Production Drugs 40

Antidote

JULY 29, 2022

Between 2009 and 2018, U.S. The process of getting a new drug to market is an expensive one. biopharmaceutical companies spent about $1 billion per drug according to an analysis published in JAMA , and other studies have found that it can cost up to $2.8 billion to bring a new therapy to market.

Clinical Trials 96

Clinical Trials Trials Therapies Pharmaceuticals 96

Broad Institute

AUGUST 31, 2023

TBD By lcopelan@broadinstitute.org August 31, 2023 Yuhan Hao Neptune Bio Related Resources [link] MIA About Current Schedule Video Playlist Resources All talks Contact us MIA Talks Search - Any - Spring 2023 Fall 2022 Spring 2022 Fall 2021 Spring 2021 Fall 2020 Spring 2020 Fall 2019 Spring 2019 Fall 2018 Spring 2018 Fall 2017 Spring 2017 Fall 2016 (..)

73

73

LifeSciVC

JANUARY 12, 2024

Starting in 2018, large rounds became more frequent in biotech venture funding. These peaked in the pandemic bubble, but have not returned to their 2018-2019 levels. Mega-rounds greater than $100M continue to be fairly common. We’ve seen at least one mega-round per week, on average, throughout 2023.

Marketing 122

Marketing Science 122

SCIENMAG: Medicine & Health

JUNE 13, 2023

Experts at Newcastle University have reviewed evidence of following the 2018 World Cancer Research Fund (WCRF) and American Institute for Cancer Research (AICR) lifestyle-based recommendations. People who adhere to global Cancer Prevention Recommendations are putting themselves at lower risk of developing the disease, new research confirms.

Disease 82

Disease Research 82

SCIENMAG: Medicine & Health

JUNE 8, 2023

ANN ARBOR—Young adults ages 19 to 30 nearly doubled their past 12-month use of non-LSD hallucinogens in the United States from 2018 to 2021, according to a study by the University of Michigan and Columbia University. In 2018, the prevalence of young adults’ past-year use of non-LSD hallucinogens was 3.4%.

68

68

Drug Channels

JULY 6, 2022

Below, I review a new survey of commercial plan sponsors and contrast the findings to a comparable survey from 2018. The boom in copay accumulators and maximizers has radically shifted payers’ views on manufacturers’ copay support programs for specialty drugs.

Drugs 98

Drugs 98

LifeSciVC

NOVEMBER 17, 2023

We’ve shared this “state of the industry” talk in past years ( 2022 , 2021 , 2020 , 2019 , 2018 ), and with this blog post are doing it again this year. We then shift to the venture ecosystem and the broader capital markets, highlighting the parallels with twenty years ago, post the genomics bubble in 2002-2003.

Science 104

Science Marketing Production Disease 104

keypoint

OCTOBER 26, 2023

2018 Nobel Laureate Dr. Jim Allison, and organizer of the 2024 Keystone Symposia on Cancer Immunotherapy, has been a regular at the Keystone Symposia meetings since 1987, predating the existence of cancer immunotherapy itself!

Doctors 92

Doctors 92

Drug Target Review

NOVEMBER 1, 2023

2018 Jun 13;5. 2018 Sep;37(2–3):509–18. He formerly worked at EMBL as a postdoctoral fellow from 2017 to 2020 where he discovered the inhibition of ATX with THC. References: Ninou I, Magkrioti C, Aidinis V. Autotaxin in Pathophysiology and Pulmonary Fibrosis. Frontiers in Medicine. Castagna D, Budd DC, Macdonald SJF, et al. J Med Chem.

Clinical Trials 134

Clinical Trials Trials Small Molecule Disease 134

FDA Law Blog: Drug Discovery

JULY 17, 2024

An Opportunity to Leverage the Newly Created Rare Disease Advisory Committee across CDER and CBER In Frank and James’ 2018 proposal there was also a recommendation for the formation of a Rare Disease Advisory Committee, which would allow FDA access to experts in the science of small trials and other aspects of rare disease research.

FDA 105

FDA Disease Clinical Pharmacology Science 105

SCIENMAG: Medicine & Health

JUNE 16, 2023

Mexican Americans consistently had the highest percentage of MAFLD, especially in 2018, although the prevalence of increase […] CHICAGO—The percent of metabolic associated fatty liver disease (MAFLD), the leading global cause of liver disease, is increasing in U.S.

Disease 65

Disease 65

SCIENMAG: Medicine & Health

JULY 19, 2023

Using an innovative method for measuring doctor turnover, Weill Cornell Medicine researchers determined that between 2010 and 2018, the annual rate at which physicians left their practices increased by 43 percent, from 5.3 percent to 7.6 percent a year.

Doctors 65

Doctors Research 65

New Drug Approvals

OCTOBER 12, 2024

2018; 32(9): 849–861. [2]. 2018 Mar;57(3):315-333. Tramiprosate was reported to inhibit Aβ42 aggregation into toxic oligomers ( Gervais et al., 2007 ; Kocis et al., Both ALZ-801 and tramiprosate are metabolized to 3-sulfopranpanoic acid (3-SPA), which is normally found in brain and also inhibits Aβ42 aggregation ( Hey et al.,

Pharmacokinetics 62

Pharmacokinetics Small Molecule Disease Licensing 62